The combination of MnO₂@Lipo-coated gefitinib and bevacizumab inhibits the development of non-small cell lung cancer

References

• Alizadeh AA, Aranda V, Bardelli A, et al. (2015). Toward understanding and exploiting tumor heterogeneity. Nat Med 21:846–53.
   PubMed Web of Science ®Google Scholar
• Allen TM, Cullis PR. (2013). Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 65:36–48.
   PubMed Web of Science ®Google Scholar
• Barenholz Y. (2003). Relevancy of drug loading to liposomal formulation therapeutic efficacy. J Liposome Res 13:1–8.
   PubMed Web of Science ®Google Scholar
• Chen H, Chen Z, Kuang Y, et al. (2018). Stepwise-acid-active organic/inorganic hybrid drug delivery system for cancer therapy. Colloids Surf B Biointerfaces 167:407–14.
   PubMed Web of Science ®Google Scholar
• Chen LJ, Yang CX, Yan XP. (2017). Liposome-coated persistent luminescence nanoparticles as luminescence trackable drug carrier for chemotherapy. Anal Chem 89:6936–9.
   PubMed Web of Science ®Google Scholar
• Drummond DC, Meyer O, Hong K, et al. (1999). Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 51:691–743.
   PubMed Web of Science ®Google Scholar
• Ghosh K, Yue CY, Sk MM, Jena RK. (2017). Development of 3D urchin-shaped coaxial manganese dioxide@polyaniline (MnO2@PANI) composite and self-assembled 3D pillared graphene foam for asymmetric all-solid-state flexible supercapacitor application. ACS Appl Mater Interfaces 9:15350–63.
   PubMed Web of Science ®Google Scholar
• Han Y, Li Y, Zhang P, et al. (2016). Nanostructured lipid carriers as novel drug delivery system for lung cancer gene therapy. Pharm Dev Technol 21:277–81.
   PubMed Web of Science ®Google Scholar
• He Q, Chen J, Yan J, et al. (2020). Tumor microenvironment responsive drug delivery systems. Asian J Pharm Sci 15:416–48.
   PubMed Web of Science ®Google Scholar
• Jin H, Wan C, Zou Z, et al. (2018). Tumor ablation and therapeutic immunity induction by an injectable peptide hydrogel. ACS Nano 12:3295–310.
   PubMed Web of Science ®Google Scholar
• Lasic DD, Frederik PM, Stuart MC, et al. (1992). Gelation of liposome interior. A novel method for drug encapsulation. FEBS Lett 312:255–8.
   PubMed Web of Science ®Google Scholar
• Li B, Rong G, Xie Y, et al. (2006). Low-temperature synthesis of alpha-MnO2 hollow urchins and their application in rechargeable Li batteries+. Inorg Chem 45:6404–10.
   PubMed Web of Science ®Google Scholar
• Liao L, Liu J, Dreaden EC, et al. (2014). A convergent synthetic platform for single-nanoparticle combination cancer therapy: ratiometric loading and controlled release of cisplatin, doxorubicin, and camptothecin. J Am Chem Soc 136:5896–9.
   PubMed Web of Science ®Google Scholar
• Liu D, Liu F, Liu Z, et al. (2011). Tumor specific delivery and therapy by double-targeted nanostructured lipid carriers with anti-VEGFR-2 antibody. Mol Pharm 8:2291–301.
   PubMed Web of Science ®Google Scholar
• Liu G, Ma J, Li Y, et al. (2017). Core-interlayer-shell Fe3O4@mSiO2@lipid-PEG-methotrexate nanoparticle for multimodal imaging and multistage targeted chemo-photodynamic therapy. Int J Pharm 521:19–32.
   PubMed Web of Science ®Google Scholar
• Liu Y, Chen XG, Yang PP, et al. (2019). Tumor microenvironmental pH and enzyme dual responsive polymer-liposomes for synergistic treatment of cancer immuno-chemotherapy. Biomacromolecules 20:882–92.
   PubMed Web of Science ®Google Scholar
• Lohcharoenkal W, Wang L, Chen YC, Rojanasakul Y. (2014). Protein nanoparticles as drug delivery carriers for cancer therapy. Biomed Res Int 2014:180549.
   PubMed Web of Science ®Google Scholar
• Lusic H, Grinstaff MW. (2013). X-ray-computed tomography contrast agents. Chem Rev 113:1641–66.
   PubMed Web of Science ®Google Scholar
• Maeda H, Wu J, Sawa T, et al. (2000). Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 65:271–84.
   PubMed Web of Science ®Google Scholar
• Papahadjopoulos D, Allen TM, Gabizon A, et al. (1991). Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci U S A 88:11460–4.
   PubMed Web of Science ®Google Scholar
• Prasad R, Chauhan DS, Yadav AS, et al. (2018). A biodegradable fluorescent nanohybrid for photo-driven tumor diagnosis and tumor growth inhibition. Nanoscale 10:19082–91.
   PubMed Web of Science ®Google Scholar
• Prasad R, Yadav AS, Gorain M, et al. (2019). Graphene oxide supported liposomes as red emissive theranostics for phototriggered tissue visualization and tumor regression. ACS Appl Bio Mater 2:3312–20.
   PubMedGoogle Scholar
• Qu Q, Zhang P, Wang B, et al. (2009). Electrochemical performance of MnO2 nanorods in neutral aqueous electrolytes as a cathode for asymmetric supercapacitors. J Phys Chem C 113:14020–7.
   Web of Science ®Google Scholar
• Selvakumar M, Srivastava P, Pawar HS, et al. (2016). On-demand guided bone regeneration with microbial protection of ornamented SPU scaffold with bismuth-doped single crystalline hydroxyapatite: augmentation and cartilage formation. ACS Appl Mater Interfaces 8:4086–100.
   PubMed Web of Science ®Google Scholar
• Wicki A, Witzigmann D, Balasubramanian V, Huwyler J. (2015). Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. J Control Release 200:138–57.
   PubMed Web of Science ®Google Scholar
• Wu M-X, Yan H-J, Gao J, et al. (2018). Multifunctional supramolecular materials constructed from polypyrrole@UiO-66 nanohybrids and pillararene nanovalves for targeted chemophotothermal therapy. ACS Appl Mater Interfaces 10:34655–63.
   PubMed Web of Science ®Google Scholar
• Yanasarn N, Sloat BR, Cui Z. (2011). Negatively charged liposomes show potent adjuvant activity when simply admixed with protein antigens. Mol Pharm 8:1174–85.
   PubMed Web of Science ®Google Scholar
• Yang G, Xu L, Chao Y, et al. (2017). Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses. Nat Commun 8:902.
   PubMed Web of Science ®Google Scholar
• Ying M, Zhan C, Wang S, et al. (2016). Liposome-based systemic glioma-targeted drug delivery enabled by all-d peptides. ACS Appl Mater Interfaces 8:29977–85.
   PubMed Web of Science ®Google Scholar
• Zamboni WC. (2005). Liposomal, nanoparticle, and conjugated formulations of anticancer agents. Clin Cancer Res 11:8230–4.
   PubMed Web of Science ®Google Scholar
• Zhang F, Chen D, Wang Y, et al. (2017). Lysosome-dependent necrosis specifically evoked in cancer cells by gold nanorods. Nanomedicine 12:1575–89.
   PubMed Web of Science ®Google Scholar
• Zhang JL, Srivastava RS, Misra RD. (2007). Core-shell magnetite nanoparticles surface encapsulated with smart stimuli-responsive polymer: synthesis, characterization, and LCST of viable drug-targeting delivery system. Langmuir 23:6342–51.
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhou W, Jia Z, et al. (2018). Polydopamine-assisted functionalization of heparin and vancomycin onto microarc-oxidized 3D printed porous Ti6Al4V for improved hemocompatibility, osteogenic and anti-infection potencies. Sci China Mater 61:579.
   Web of Science ®Google Scholar
• Zhang Y, Wu L, Jiang C, Yan B. (2015). Reprogramming cellular signaling machinery using surface-modified carbon nanotubes. Chem Res Toxicol 28:296–305.
   PubMed Web of Science ®Google Scholar
• Zhu S, Chen Z, Wang L, et al. (2018). A combination of SAHA and quinacrine is effective in inducing cancer cell death in upper gastrointestinal cancers. Clin Cancer Res 24:1905–16.
   PubMed Web of Science ®Google Scholar
• Zununi Vahed S, Salehi R, Davaran S, Sharifi S. (2017). Liposome-based drug co-delivery systems in cancer cells. Mater Sci Eng C Mater Biol Appl 71:1327–41.
   PubMed Web of Science ®Google Scholar